No-reflow is responsible for 40% of the primary percutaneous coronary intervention without
complete myocardial reperfusion despite successful reopening of the infarct-related artery …

Microvascular dysfunction is well established as an early and rate-determining factor in the
injury response of tissues to ischemia and reperfusion (I/R). Severe endothelial cell …

Although mean platelet volume (MPV) is an independent correlate of impaired angiographic
reperfusion and 6-month mortality in ST-segment elevation myocardial infarction (STEMI) …

Background No-reflow (NR) is the inability to achieve adequate myocardial perfusion
despite successful restoration of attegrade blood flow in the infarct-related artery after …

Conditioning, the recruitment of endogenous cytoprotective pathways that protect the
myocardium against injurious ischaemia/reperfusion injury, has developed into a range of …

目的: 探讨冠状动脉(冠脉) 内逆向应用重组人尿激酶原联合经皮冠脉介入治疗(PCI) 对ST
段抬高型心肌梗死(STEMI) 患者预后的影响. 方法: 选择心内科行急诊PCI 的STEMI 患者120 例 …

AIMS: Adjunctive therapy with adenosine has been shown to improve coronary flow in
patients with acute coronary syndromes (ACS); it is unclear, however, whether adenosine …

The no-reflow phenomenon (NRP) is defined as the lack of adequate myocardial tissue
perfusion despite a patent epicardial coronary artery. The incidence of NRP varies between …

Background The incidence and prognosis of coronary slow-flow (CSF) and no-reflow
phenomenon (NRP) in patients with coronary chronic total occlusion (CTO) who underwent …

A high proportion of primary percutaneous coronary interventions performed in the setting of
acute myocardial infarction, concur with inadequate myocardial perfusion at the …